FDA investigates allegations against St. Jude Medical

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA is investigating allegations about cybersecurity flaws in St. Jude Medical’s cardiac devices, Reuters reports.

In late August, research firm Muddy Waters wrote a report warning investors that St. Jude’s pacemakers and defibrillators could be susceptible to hacking. Muddy Waters also said it had shorted St. Jude Medical’s stock.

St. Jude Medical then filed a lawsuit against Muddy Waters and MedSec Holdings, a cybersecurity research firm that warned Muddy Waters about the potential hacking issues.

“Regardless of the way a vulnerability comes to our attention, we take those allegations very, very seriously,” Suzanne Schwartz, MD, MBA, an FDA official, told Reuters in a telephone interview. “We are putting all of our focus on making sure that we have an understanding of what these allegations are and do a thorough investigation of the claims.”

Read the full Reuters article below: